These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 35927634

  • 1. Association of serum apoA-I with in-stent restenosis in coronary heart disease.
    Wang X, Zhang M, Cheng J, Zhou H.
    BMC Cardiovasc Disord; 2022 Aug 04; 22(1):355. PubMed ID: 35927634
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M, Yan X, Wu W.
    BMC Cardiovasc Disord; 2021 Sep 17; 21(1):446. PubMed ID: 34535088
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Liu W, Ding K, Bao J, Hu Y, Gui Y, Ye L, Wang L.
    Coron Artery Dis; 2023 Dec 01; 34(8):589-594. PubMed ID: 37855441
    [Abstract] [Full Text] [Related]

  • 6. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T, Sun JL, Zhang J.
    Coron Artery Dis; 2020 Nov 01; 31(7):586-589. PubMed ID: 32271235
    [Abstract] [Full Text] [Related]

  • 7. Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis.
    Coughlan JJ, Aytekin A, Lahu S, Scalamogna M, Wiebe J, Pinieck S, Kufner S, Xhepa E, Joner M, Kuna C, Voll F, Laugwitz KL, Schunkert H, Kastrati A, Cassese S.
    EuroIntervention; 2023 Apr 03; 18(16):e1328-e1338. PubMed ID: 36785947
    [Abstract] [Full Text] [Related]

  • 8. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C, under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology.
    Circ Cardiovasc Interv; 2016 Jul 03; 9(7):. PubMed ID: 27412868
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictive Value Analysis of in-Stent Restenosis Within Three Years in Older Acute Coronary Syndrome Patients: A Two-Center Retrospective Study.
    Zhou J, Chai D, Dai Y, Wang A, Yan T, Lu S.
    Clin Appl Thromb Hemost; 2022 Jul 03; 28():10760296221107888. PubMed ID: 35706375
    [Abstract] [Full Text] [Related]

  • 12. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May 03; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X, Lu W, Wang X, Pan L, Fu W, Liu Q, Han Z, Sun G, Qin X, Li R, Zheng X, Shan Y, Qiu C.
    Int J Cardiovasc Imaging; 2020 Feb 03; 36(2):171-178. PubMed ID: 31919705
    [Abstract] [Full Text] [Related]

  • 18. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y.
    Cardiovasc Diabetol; 2021 Jul 08; 20(1):137. PubMed ID: 34238294
    [Abstract] [Full Text] [Related]

  • 19. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A, ISAR-LEFT MAIN Study Investigators.
    JACC Cardiovasc Interv; 2014 Jan 08; 7(1):29-36. PubMed ID: 24332416
    [Abstract] [Full Text] [Related]

  • 20. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis.
    Nakamura D, Dohi T, Ishihara T, Kikuchi A, Mori N, Yokoi K, Shiraki T, Mizote I, Mano T, Higuchi Y, Yamada T, Nishino M, Sakata Y.
    EuroIntervention; 2021 Aug 27; 17(6):489-496. PubMed ID: 32985411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.